[go: up one dir, main page]

DE602004032107D1 - Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids - Google Patents

Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids

Info

Publication number
DE602004032107D1
DE602004032107D1 DE602004032107T DE602004032107T DE602004032107D1 DE 602004032107 D1 DE602004032107 D1 DE 602004032107D1 DE 602004032107 T DE602004032107 T DE 602004032107T DE 602004032107 T DE602004032107 T DE 602004032107T DE 602004032107 D1 DE602004032107 D1 DE 602004032107D1
Authority
DE
Germany
Prior art keywords
nell peptide
bone
making
expression systems
nell1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004032107T
Other languages
English (en)
Inventor
Kang Ting
Shunichi Kuroda
Ben Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/029281 external-priority patent/WO2004024893A2/en
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of DE602004032107D1 publication Critical patent/DE602004032107D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004032107T 2003-02-07 2004-02-09 Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids Expired - Lifetime DE602004032107D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44567203P 2003-02-07 2003-02-07
PCT/US2003/029281 WO2004024893A2 (en) 2002-09-13 2003-09-15 Nell-1 enhanced bone mineralization
PCT/US2004/003808 WO2004072100A2 (en) 2003-02-07 2004-02-09 Nell peptide expression systems and bone formation activity of nell peptide

Publications (1)

Publication Number Publication Date
DE602004032107D1 true DE602004032107D1 (de) 2011-05-19

Family

ID=32869406

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004032107T Expired - Lifetime DE602004032107D1 (de) 2003-02-07 2004-02-09 Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids

Country Status (9)

Country Link
US (3) US7544486B2 (de)
EP (1) EP1594889B1 (de)
JP (1) JP2007524360A (de)
CN (1) CN101018562A (de)
AT (1) ATE504649T1 (de)
CA (1) CA2515208A1 (de)
DE (1) DE602004032107D1 (de)
ES (1) ES2366950T3 (de)
WO (1) WO2004072100A2 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005088A (en) 1996-03-19 1999-12-21 Otsuka Pharmaceutical Co., Ltd. Human NPIK gene
JP3646191B2 (ja) * 1996-03-19 2005-05-11 大塚製薬株式会社 ヒト遺伝子
US7544486B2 (en) * 2003-02-07 2009-06-09 The Regents Of The University Of California Nell peptide expression systems and bone formation activity of nell peptide
US7687462B2 (en) * 1999-10-05 2010-03-30 The Regents Of The University Of California Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
US7884066B2 (en) 1999-10-05 2011-02-08 The Regents Of The University Of California NELL-1 enhanced bone mineralization
WO2005049063A2 (en) * 2003-11-19 2005-06-02 Develogen Aktiengesellschaft Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
US7691607B2 (en) * 2004-02-09 2010-04-06 The Regents Of The University Of California Expression system of NELL peptide
WO2006038107A2 (en) * 2004-08-30 2006-04-13 Mengsu Yang Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein
EP1851237A4 (de) * 2005-02-16 2009-01-07 Univ California Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen
BRPI0715469A2 (pt) * 2006-07-11 2013-03-12 Qps Llc composiÇÕes farmacÊuticas para a liberaÇço sustentada de peptÍdeos
JP2008212265A (ja) * 2007-03-01 2008-09-18 Niigata Univ 培養人工骨及びその作製方法
US7910542B2 (en) 2007-09-28 2011-03-22 Ut-Battelle, Llc Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1
WO2009045800A1 (en) * 2007-09-28 2009-04-09 Culiat Cymbeline T Treatment of cardiovascular disorders using the cell differentiation signaling protein nell1
EP2214697A4 (de) * 2007-10-30 2011-05-18 Univ California Nell-1-zusammensetzungen
JP2011016723A (ja) * 2007-11-02 2011-01-27 Katayama Kagaku Kogyo Kk 骨及び軟骨形成タンパク質を含有する医薬品及び医療器具
KR20110076874A (ko) * 2008-08-04 2011-07-06 각코 호징 쇼와 다이가쿠 Ｎｅｌｌ―１에 의한 조직·장기 이소재생 제어기술
GB2463474B (en) * 2008-09-11 2012-05-02 Agency Science Tech & Res Therapeutic bone growth and regeneration
EP2350286B1 (de) * 2008-10-07 2016-07-20 The Regents of The University of California Herstellung rekombinanter nell-proteine
US20110002893A1 (en) * 2008-11-03 2011-01-06 Ut-Battelle, Llc Diagnosis and treatment of congenital heart defects using nell1
EP2411406B1 (de) * 2009-03-25 2017-03-01 The Regents of The University of California Isoformes nell-1-peptid
WO2011022070A2 (en) * 2009-08-20 2011-02-24 The Regents Of The University Of California Perivascular stem cell composition for bone
EP2525808A2 (de) 2010-01-19 2012-11-28 The Trustees Of Columbia University In The City Of New York Osteocalcin als behandlungsmittel für männliche fortpflanzungsstörungen
WO2011091244A1 (en) * 2010-01-21 2011-07-28 NellOne Therapeutics, Inc. Methods to treat or prevent a skin condition using a nell1 peptide
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
WO2014152497A2 (en) 2013-03-15 2014-09-25 The Trustees Of Columbia University In The City Of New York Osteocalcin as a treatment for cognitive disorders
EP3027235A1 (de) 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Aus einem azellulären weichgewebe gewonnene matrizen und verfahren zur herstellung davon
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
EP3226889A4 (de) 2014-11-19 2018-11-21 The Trustees of Columbia University in the City of New York Osteocalcin zur behandlung von gebrechlichkeit im zusammenhang mit alterung
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US10973953B1 (en) 2016-08-18 2021-04-13 Musculoskeletal Transplant Foundation Methods and compositions for preparing transplant tissue
US10752663B2 (en) 2016-08-29 2020-08-25 NellOne Therapeutics, Inc. Methods and compositions for regenerating tissues
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
EP3852823A4 (de) 2018-09-17 2022-05-04 Rejuvablast LLC Kombinationstransplantate für gewebereparatur- oder regenerationsanwendungen
EP3744356A1 (de) 2019-05-31 2020-12-02 Musculoskeletal Transplant Foundation Aus einem azellulären weichgewebe gewonnene matrizen und verfahren zur herstellung davon
CN110420350B (zh) * 2019-08-28 2021-10-22 深圳先进技术研究院 复合生物玻璃的粘附温敏水凝胶及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394370A (en) 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US4409332A (en) 1982-01-12 1983-10-11 Jefferies Steven R Collagen-enzyme conjugates that exhibit no inflammatory response and method for making the same
US5395502A (en) * 1988-11-14 1995-03-07 Anthony R. Torres Apparatus for performing and universally detecting capillary isoelectric focusing without mobilization using concentration gradient imaging systems
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5674844A (en) 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5674725A (en) 1991-07-11 1997-10-07 British Technology Group Limited Implant materials having a phosphatase and an organophosphorus compound for in vivo mineralization of bone
US5385887A (en) 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6083690A (en) 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
US6352972B1 (en) 1995-06-06 2002-03-05 Marcel E. Nimni Bone morphogenetic proteins and their use in bone growth
US6008208A (en) 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
US6048964A (en) 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6200606B1 (en) 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US6005088A (en) 1996-03-19 1999-12-21 Otsuka Pharmaceutical Co., Ltd. Human NPIK gene
JP3646191B2 (ja) * 1996-03-19 2005-05-11 大塚製薬株式会社 ヒト遺伝子
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
US6462019B1 (en) 1998-07-10 2002-10-08 Osteoscreen, Inc. Inhibitors of proteasomal activity and production for stimulating bone growth
IL141061A0 (en) * 1998-08-10 2002-02-10 Urogenesys Inc Bpc-1 a secreted brain specific protein expressed and sectreted by prostate and bladder cancer cells
US20060111313A1 (en) 2002-09-13 2006-05-25 Kang Ting Nell-1 enhanced bone mineralization
US7544486B2 (en) * 2003-02-07 2009-06-09 The Regents Of The University Of California Nell peptide expression systems and bone formation activity of nell peptide
US7052856B2 (en) * 1999-10-05 2006-05-30 The Regents Of The University Of California NELL-1 enhanced bone mineralization
US20030039968A1 (en) 2001-07-10 2003-02-27 Applera Corporation Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
TWI296483B (en) * 2005-12-07 2008-05-01 Marketech Int Corp Apparatus and method for adjusting input image based on characteristics of display system

Also Published As

Publication number Publication date
US20060292670A1 (en) 2006-12-28
US20100249376A1 (en) 2010-09-30
ATE504649T1 (de) 2011-04-15
EP1594889B1 (de) 2011-04-06
CN101018562A (zh) 2007-08-15
WO2004072100A3 (en) 2007-03-15
US8048646B2 (en) 2011-11-01
WO2004072100A2 (en) 2004-08-26
ES2366950T3 (es) 2011-10-26
US7544486B2 (en) 2009-06-09
US20090226505A1 (en) 2009-09-10
JP2007524360A (ja) 2007-08-30
EP1594889A4 (de) 2008-03-19
EP1594889A2 (de) 2005-11-16
CA2515208A1 (en) 2004-08-26
US7807787B2 (en) 2010-10-05

Similar Documents

Publication Publication Date Title
DE602004032107D1 (de) Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
TW200638934A (en) Heteroaryl compounds as P2Y1 receptor inhibitors
CY1111212T1 (el) Θειικες ενωσεις ως αναστολεις της πρωτεασης σερινης ns3 του ιου της ηπατιτιδας γ
MY151036A (en) Synthesis of (r)-n-methylnaltrexone
DE60229530D1 (de) Substituierte piperazine als modulatoren des melanocortinrezeptors
MY148851A (en) Dihydropyridine derivatives as useful as protein kinase inhibitors
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
MY162157A (en) Substituted indole mcl-1 inhibitors
PL374080A1 (en) Processes for the preparation of fibrinogen
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
MY149041A (en) Novel fused pyrrolocarbazoles
ATE502924T1 (de) Lineare harnstoffmimetika-antagonisten des p2y1- rezeptors zur behandlung von thromboseleiden
DE50310579D1 (de) Furancarboxamide
TW200716132A (en) Novel chemical compounds
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
ATE546154T1 (de) Anti-angiogenetisches mittel und seine verwendung bei der krebsbehandlung
UA87117C2 (ru) Применение пептидных соединений для лечения центральной невропатической боли
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
DE50303586D1 (de) Methylthiophencarboxanilide
WO2006052840A3 (en) Bone tropic peptides
TW200716579A (en) Novel chemical compounds
TW200738689A (en) Salts and polymorphs of a VEGF-R inhibitor